From: Evaluation of ocular pulse amplitude in non-arteritic anterior ischaemic optic neuropathy
Study group | Control group | p value | |
---|---|---|---|
(n = 30 eyes) | (n = 31 eyes) | ||
Mean age (year ± SD) | 54.67 ± 10.54 | 53.39 ± 6.67 | 0.575 |
Gender, no. of females (%) | 16 (53.3%) | 21 (67.7%) | 0.249 |
BMI, mean (SD), kg/m2 | 29.08 ± 5.23 | 27.77 ± 4.67 | 0.304 |
Hypertension n,(%) | 12 (40.0%) | 9 (29.0%) | 0.367 |
SBP, mmHg | 122,83 ± 13.11 | 118.71 ± 15.97 | 0.276 |
DBP, mmHg | 77.70 ± 7.66 | 75.00 ± 11.25 | 0.279 |
Ischaemic heart disease n, (%) | 4 (13.3%) | 3 (9.7%) | 0.707 |
DM n, (%) | 9 (30.0%) | 7 (22.6%) | 0.510 |
Hyperlipidemia n, (%) | 8 (26.7%) | 4 (12.9%) | 0.176 |
BCVA | 0.35 ± 0.37 | 0.96 ± 0.09 | <0.001 |
Spheric equivalant, mean | 0.38 ± 1.43 | 0.47 ± 1.12 | 0.788 |
Mean GAT, mmHg ± SD | 13.73 ± 2.30 | 14.84 ± 2.74 | 0.094 |
Mean DCT, mmHg ± SD | 13.58 ± 1.81 | 14.20 ± 2.22 | 0.240 |
Mean OPA, mmHg ± SD | 2.01 ± 0.69 | 1.97 ± 0.68 | 0.839 |
CCT, μm | 536.47 ± 35.04 | 546.61 ± 30.03 | 0.229 |